Cart
sales@molnova.com
3',4'-Dihydroxyacetophenone
CAS No. 1197-09-7
3',4'-Dihydroxyacetophenone( —— )
Catalog No. M17870 CAS No. 1197-09-7
3', 4'-Dihydroxyacetophenone is an active constituent of Chinese medicine. It is platelet aggregation Inhibitor and also has anti-arrhythmia activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 26 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3',4'-Dihydroxyacetophenone
-
NoteResearch use only, not for human use.
-
Brief Description3', 4'-Dihydroxyacetophenone is an active constituent of Chinese medicine. It is platelet aggregation Inhibitor and also has anti-arrhythmia activity.
-
Description3', 4'-Dihydroxyacetophenone is an active constituent of Chinese medicine. It is platelet aggregation Inhibitor and also has anti-arrhythmia activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorPlatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1197-09-7
-
Formula Weight152.14
-
Molecular FormulaC8H8O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (328.62 mM)
-
SMILESC(=O)(C)c1cc(c(cc1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sun YP, et al. Zhonghua Fu Chan Ke Za Zhi. 1992 Jan;27(1):9-11, 57.
molnova catalog
related products
-
(Z)-SU14813
(Z)-SU14813 is a novel tyrosine kinase inhibitor with anticardiogenic and antitumor activity that inhibits VEGFR-2, PDGFR-β, and FLT3 phosphorylation in xenograft tumors in a dose- and time-dependent manner.
-
Tafetinib
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
-
SU 5616
SU 5616 (WAY-608241) regulates abnormal cell proliferation and modulates tyrosine kinase signaling.
